FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
April 25, 2023 at 13:20 PM EDT
The FDA's approval requires Biogen to further study its ALS drug tofersen to further verify its clinical benefits.
|
||||||||||||
![]() |
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |